Power Law company profile

Edgewise Therapeutics

Biotech & Life Sciences · Boulder, United States · Founded 2017 · IPO 2021 Unicorn

A new biotech company harnessing proven expertise and understanding of skeletal muscle

Valuation

$2.80B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

15 investors on Edgewise Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 15 investors entered at this stage

New Leaf Venture Partners

Viking Global Investors

Novo Holdings

Novo Seeds

Deerfield

Novo Ventures

Cormorant Asset Management

RA Capital Management

Logos Capital

Citadel

OrbiMed

Janus Henderson Investors

U.S. Venture Partners

Cure Duchenne

Wellington Management

Global footprint

Where Edgewise Therapeutics has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States97.1%

🇬🇧 United Kingdom1.9%

🇨🇭 Switzerland1%

3 countries shown

Web traffic by country

7.6K monthly visits
across markets

🇺🇸 United States94.7%

🇮🇳 India5.3%

Top 2 markets shown

Patent intelligence

$15M patent portfolio · 15 active families

Estimated portfolio value

$15M

0.55% of market cap · 2.4× the top peer DICE Therapeutics ($6M)

15 active patent families

Where Edgewise Therapeutics innovates Pharmaceutical drugPyridazinePharmacologyDepressantQuinazolinone

Where Edgewise Therapeutics concentrates vs peers

Each axis is a top-10 topic across Edgewise Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Edgewise Therapeutics

An AI-synthesized read of the highest-engagement posts about Edgewise Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Edgewise Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles